Menter, T., et al. Analysis of the microenvironment of follicular lymphoma by gene expression analysis: importance of the Th17 axis. Abstract presented at the 104th Annual Meeting of the German Society for Pathology 2020 Jun 4-6; Virtual Conference
Inaki, K., et al. Pan-cancer gene expression analysis of tissue microarray using EdgeSeq Oncology biomarker Panel and a cross-comparison with ERBB3 immunohistochemical analysis. Abstract presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 June 22-24. Online Proceedings. Session PO.MCB09.01 Functional Genomics and Other Topics
Download pdf 1.1MB
View External Link
O'Rourke, D., et al. Comparison of HTG-edge targeted RNA sequencing platform with whole transcriptome RNA sequencing for clinical biomarker studies. Abstract presented at: American Association for Cancer Research (AACR) Virtual Annual Meeting 2020 June 22-24. Online Proceedings. Session PO.CL11.02 Predictive Biomarkers for Treatment Efficacy 1
Download pdf 249KB
View External Link
Moura, D. S., et al. Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study. J Clin Oncol 38: 2020 (suppl; abstr 11546). DOI: 10.1200/JCO.2020.38.15_suppl.11546
Download jpg 6.0MB
View External Link
Ran, D., et al. Platform comparison of HTG edgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens. J Clin Oncol 38:2020 (suppl; abst 3566).
Download jpg 2.7MB
View External Link
Xu, J., et al. Association between immune and tumor gene signatures with response or resistance to tislelizumab monotherapy or in combination with chemotherapy in gastroesophageal adenocarcinoma. J Clin Oncol 38: 2020 (suppl; abstr 3115).
Desai, J., et al. Immune- and tumor-intrinsic gene expression profiles of response or resistance to tislelizumab as monotherapy or in combination with chemotherapy in non-small cell lung cancer (NSCLC). J Clin Oncol 38: 2020 (suppl; abstr e15258).
Kim, E., et al. Integrated-omics of MRI-visible and -invisible prostate cancer identifies molecular correlations with clinical outcome. J Clin Oncol 38: 2020 (suppl; abstr e17506). DOI:10.1200/JCO.2020.38.15_suppl.e17506.
Ebrahimi, G., et al. Serum Versus Peripheral Blood Mononuclear Cells (PBMCs): Different MicroRNA Profiles in Sarcoidosis Patients. American Journal of Respitory and Critical Care Medicine AJRCCM (2020) Abstract B35
Buschur, K., et al. Vaping-Associated Variation in MicroRNA Expression in Circulating Extraceullular Vesicles. American Journal of Respitory and Critical Care Medicine AJRCCM (2020) Abstract A29.
Danza, J., et al. HLA-E Expression Predicts Progression, Therapeutic Response and Overall Survival in Patients with Bladder Cancer. The Journal of Urology 2020 APR: 203(4) e228-e229.
Hierro, C., et al. FGFR1-4 High mRNA Expression (mRNAh) as Predictive Biomarker for FGFR Inhibitors in Breast Cancer (BC). Annals of Oncology 2020 MAR:31(S1),S8-S9., Abstract 29P.
Page last updated September 21, 2020